Lee’s PHARM

Hong Kong, China Founded: 2002 • Age: 24 yrs
Innovative biopharmaceutical products are developed to address unmet medical needs.
Request Access

About Lee’s PHARM

Lee’s PHARM is a company based in Hong Kong (China) founded in 2002.. The company has 1,020 employees as of December 31, 2024. Lee’s PHARM offers products and services including Pharmaceutical Products and Research and Development Services.

  • Headquarter Hong Kong, China
  • Employees 1020 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lee's Pharmaceutical Holdings Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $180.26 M (USD)
    32.95
    as on Dec 31, 2024
  • Net Profit
    $11.99 M (USD)
    457.55
    as on Dec 31, 2024
  • EBITDA
    $28.45 M (USD)
    101.21
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    1020

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Lee’s PHARM

Lee’s PHARM is a publicly listed company on the HKEX with ticker symbol 950 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: HKEX · Ticker: 950 . Sector: Health technology · Hong Kong

Products & Services of Lee’s PHARM

Lee’s PHARM offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Research and Development Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Various pharmaceutical products are developed for therapeutic uses, stemming from internal R&D and partnerships

Clinical trials and product pipelines are managed to advance medical frontiers and address unmet needs

People of Lee’s PHARM
Headcount 1000-5000
Employee Profiles 4
Board Members and Advisors 6
Employee Profiles
People
Brian L.
Senior Director, Group IT
People
Lee Siu Fong
Management Committee Members
People
Ivan Lee
Director Of Sales And Marketing

Unlock access to complete

Funding Insights of Lee’s PHARM

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Lee’s PHARM

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lees PHARM

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lee’S Pharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lee’s PHARM

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lee’S Pharm

Frequently Asked Questions about Lee’s PHARM

When was Lee’s PHARM founded?

Lee’s PHARM was founded in 2002.

Where is Lee’s PHARM located?

Lee’s PHARM is headquartered in Hong Kong, China.

Who is the current CEO of Lee’s PHARM?

Benjamin Li is the current CEO of Lee’s PHARM.

How many employees does Lee’s PHARM have?

As of Dec 31, 2024, the latest employee count at Lee’s PHARM is 1,020.

What is the annual revenue of Lee’s PHARM?

Annual revenue of Lee’s PHARM is $180.26M as on Dec 31, 2024.

What does Lee’s PHARM do?

The company was founded in 2002 in Hong Kong, China, within the biopharmaceutical sector. Research and development efforts are conducted internally and through collaborations to produce pharmaceutical products. Manufacturing occurs at company-owned facilities. The portfolio encompasses treatments for rare diseases, with participation in industry conferences. Investor relations and drug safety details are provided for stakeholders.

What products or services does Lee’s PHARM offer?

Lee’s PHARM offers Pharmaceutical Products and Research and Development Services.

Is Lee’s PHARM publicly traded?

Yes, Lee’s PHARM is publicly traded on HKEX under the ticker symbol 950.

What is Lee’s PHARM's ticker symbol?

The ticker symbol of Lee’s PHARM is 950 on HKEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available